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Objective: To evaluate the validity of the IgG avidity test in the serodiagnosis of acute T: gondii infection; t o  verify the 
maturation of IgG avidity during the course of infection; t o  observe whether the kinetics of IgG maturation could be 
affected by antibiotic treatment. 
Methods: Serial serum samples, collected in three Italian hospitals (Perugia, Treviso and Bologna), from untreated and 
antibiotic-treated patients with primary toxoplasmic infection, were assayed for IgG avidity, and IgM and IgA positivity. 
Single serum samples from patients at different stages of infection were assayed for IgG avidity and the results were 
correlated to the likely stage of infection. 
Results: The IgG avidity value increased from 3.5% in the first month to  38.7% 1 year from the onset of infection. 
Antibiotic-treated patients showed significantly different values of IgG avidity at 2 and 4 months after the onset of 
infection. In single serum samples the IgG avidity values correlated with the likely stage of infection. 
Conclusions: The IgG avidity test was confirmed as a useful tool in  the serodiagnosis of acute T: gondii infection and 
could be predictive of the stage of infection. Antibiotic treatment may affect the kinetics of the maturation of IgG avidity. 
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INTRODUCTION 
The most crucial problem in the diagnosis of infectious 
diseases acquired during pregnancy is to establish the 
time of onset. The rate of transmission to the fetus and 
the severity of damage are related to the trimester of 
pregnancy in which the infection occurs. Toxoplasma 
gondii infection is transmitted from the mother to the 
fetus at an increasing rate, from 20% to 70%, depending 
on gestational age [I] .  The diagnosis of toxoplasmosis, 
often asymptomatic, is based mainly on serologic tests 
which detect specific IgG and IgM antibodies. The 
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absence of IgM is usually indicative of past infection, 
whereas the presence of antibodies is an indication of 
acute infection. IgM antibodies can be detected in the 
sera for a year or more; however, if used alone they have 
a poor diagnostic value [2]. In some cases they are 
reported as natural antibodies, without infection [3,4]. 
The recent introduction of specific IgA detectioii has 
greatly improved the serodiagnosis of acute infection, 
but there are still discordant reports about IgA duration 
[5], although they are detected mainly in the sera of 
patients with acute infection and rarely in chronically 
infected patients [6-81. An assay measuring the 
antigen-binding avidity (functional affinity) of IgG 
antibodies against T gondii has been developed to 
separate, by treatment with a denaturing agent, the IgC 
produced at the early stage of infection (low avidity) 
from those produced in the past (high avidity) [9-121. 
In the present study, serial serum samples, collected in 
three Italian hospitals (Perugia, Treviso and Bologna) 
from patients with primary toxoplasmic infection, were 
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examined to evaluate the maturation of IgG avidity, also 
in the presence of antibiotic treatment. In addition, 
single serum samples from patients at  different stages of 
infection, classified on the basis of IgG, IgM and IgA 
antibody positivity as having acute, recently acquired or 
past infection, were examined to evaluate the signi- 
ficance of the IgG avidity test as compared to standard 
diagnostic procedures. 
MATERIALS AND METHODS 
Sera 
Serum samples were obtained from two groups. Group 
I consisted of 224 serial serum samples collected from 
47 patients, 28 women and 19 men, with clinical 
and/or serologic evidence of primary 7: gondii in- 
fection. The diagnostic criteria were seroconversion in 
Toxoplasma-specific antibodies (8 patients) and lymph- 
adenopathy (39 patients); in these patients the date of 
onset of symptoms was known. Sequential specimens 
were collected at  about monthly intervals for 12 
months or more after the onset of infection from 12 of 
the 47 patients. The samples were divided into two 
groups: 115 sera from 23 patients not receiving any 
antibiotic treatment, and 109 sera from 24 patients 
treated with antibiotics. Group I1 consisted of 261 
single serum samples fiom patients with a serologic 
pattern that identified the probable stage of infection as 
follows: 
1. Acute infection - 95 specimens: IgG+, IgM', IgA+. 
2. Recently acquired infection - 67 specimens: IgG', 
3. Past infection - 99 specimens: IgG+, IgM-, IgA-. 
IgM+, IgA-. 
Serologic tests 
IgG antibodies were detected by two enzyme immuno- 
assays (Sorin, Saluggia, Italy; Sanofi Diagnostics 
Pasteur, Marnes la Coquette, France) and the titers 
were expressed as IU/niL. IgM antibodies were 
detected by two y-capture enzyme immunoassays 
(Sorin, Sanofi Diagnostics Pasteur). IgA antibodies 
were determined by modification of an iinmuno- 
sorbent agglutination assay (I@ ISAGA-bioM6rieux 
Italia, Rome, Italy), obtained by replacing the 
antihuman IgM-coated microtiter wells with rabbit 
antihuman IgA-coated wells at  a concentration of 
1 yg/mL (Behring, Scoppito, Italy). 
The IgG avidity test was performed as described by 
Hedman et al. [9], using a commercial kit (Labsystems 
Oy, Helsinki, Finland) and following the instructions 
of the manufacturer. The results were interpreted as 
follows: 
0 IgG avidity <15%: acute infection (low avidity). 
0 IgG avidity 16-30%: possible primary infection during 
0 IgG avidity >30%: primary infection excluded within 
the last 6 months. 
the last 3 months (high avidity). 
Statistical analysis 
Differences in the values of IgG avidity between 
antibiotic-treated and untreated patients were evaluated 
by the Mann-Whitney U test. 
Differences in the values of IgG avidity between 
the stages of infection were evaluated by the Student's 
t-test. 
RESULTS 
Patients with primary toxoplasmic infection 
IgG avidity 
The maturation of IgG avidity was studied in 224 
serum samples obtained during the course of T gondii 
infection as shown in Table 1. The mean values of IgG 
avidity in all patients are reported in Figure 1. IgG 
avidity increased from 3.5% in the first month to 38.7% 
1 year after the onset of infection. The cut-off value of 
IgG avidity, 15%, was reached at the fourth month after 
the onset of infection. 
IgM and igA 
The mean values of IgG avidity together with the rate 
of positivity for IgM and IgA are reported in Figure 2. 
No significant differences were found between the two 
commercial kits used for the detection of IgM (data not 
shown). IgM antibodies were present in 100% of the 
samples collected during the first months after the onset 
of the infection. Their disappearance from the serum 
was slow; in fact, a high rate of positivity (about 80%) 
was maintained for 7 to 8 months and antibodies were 
detected in more than 50% of the samples after 1 year. 
O n  the contrary, IgA antibodies showed higher rates of 
positivity during the first 3 months after the onset of 
Table 1 Patients with primary toxoplasmic infection 
Time after onset of infection Serum sample5 
(months) (No.) 
1 46 
2 41 
3 29 
4 24 
5-6 40 
7-8 13 
9-10 14 
11-212 17 
224 
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Figure 1 Maturation of IgG avidity in patients with 
primary toxoplasmic infection. Mean values k standard 
errors are represented. The cut-off value, 15%, is indicated 
by the straight line. 
infection and were present in only 15% of the samples 
at 7 to 8 months. After this time, they were never 
detected. 
Influence of antibiotic treatment on serologic markers 
IgG avidity 
The niaturation of IgG avidity in untreated and anti- 
biotic-treated patients was compared. The results are 
reported in Table 2. The values in untreated patients 
showed a gradual increase, reaching about 12% at the 
second month after the onset of infection. At this time, 
the mean value of IgG avidity in antibiotic-treated 
patients was significantly lower (4.6%). During the 
course of infection, the IgG avidity value increased to 
27% at the fourth month in untreated patients; this 
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Figure 2 Maturation of IgG avidity (+) and IgM (0) 
and IgA (w) positivity in patients with primary toxoplasmic 
infection. The cut-off value, 15%, is indicated by the 
straight line. 
value was significantly higher than that found in 
antibiotic-treated patients (8.7%). At 5 months from 
the onset of infection, the data were similar. The 
distribution of IgG avidity values in the two groups is 
reported in Figure 3. In untreated patients a broad 
scattering of the values was observed, whereas, in 
treated patients, almost all values were below the cut- 
off limit in the first 4 months after the onset of 
infection. 
IgM and IgA 
The rate of IgM and IgA positivity in serum samples 
from untreated and antibiotic-treated patients is shown 
in Figures 4 and 5, respectively. No significant differ- 
ences between the two groups of patients were 
observed, even if IgA seemed to decrease at a faster rate 
in the antibiotic-treated patients. In fact, IgAs were 
detected in 56.2% of the samples in the treated group 
of patients after 3 months, while they were still present 
in 92% of the samples in the untreated group. 
Furthermore, 5 to 6 months after the onset ofinfection, 
IgA positivity in treated and untreated patients was 
17.6% and 43.5%, respectively. To verifj. the influence 
of antibiotic treatment on the duration of IgM and IgA, 
a greater number of patients should be studied. 
Table 2 IgG avidity in untreated and antibiotic-treated patients with primary toxoplasmic infection 
Serum samples IgG aviditya 
“1 (W 
Tiine after onset of 
infection (months) Untreated Treated Untreated Treated 
1 24 22 3.8 3.0 
2 20 21 12.4 4.6” 
3 13 16 12.9 9.8 
4 9 15 27.1 8.7* 
5-6 23 17 27.0 22.2 
2 7  26 18 30.4 31.3 
“The iiiean values of IgG avidity are represented. 
“W 0.005 (antibiotic-treated versus untreated patients) 
28 Cl in ica l  M i c r o b i o l o g y  a n d  In fec t ion ,  V o l u m e  2 N u m b e r  1 ,  August  1996 
95 - 
90 
85 
80 
75 
70 
65 
Patients at different stages of infection 
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acquired, and past, according to the serologic profile 
obtained by the detection of IgG, IgM and IgA, as 
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Figure 3 Distribution of IgG avidity values in untreated 
(A) and antibiotic-treated (B) patients with primary 
toxoplasmic infection. The cut-off value, 15%, is indicated 
by the straight lines. 
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Figure 4 Maturation of IgG avidity (t) and IgM (0) 
and IgA (B) positivity in untreated patients with primary 
toxoplasmic infection. The cut-off value, 15%, is indicated 
by the straight line. 
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Figure 5 Maturation of IgG avidity (t) and IgM (0) 
and IgA (m) positivity in antibiotic-treated patients with 
primary toxoplasmic infection. The cut-off value, 15%, is 
indicated by the straight line. 
reported in Materials and Methods. All serum samples 
were then tested for IgG avidity; the values are reported 
in Figure 6. The distribution of the values strictly 
correlated with the stage of infection. In fact, in the 
acute stage almost all patients (95) showed an IgG 
avidity (mean value 6.4%) below the cut-off value, 
while in the 67 patients recently infected, the IgG 
avihty mean value was 19.9%. In the 99 patients with 
past infection, the IgG avidity inean value was 38.8%. 
The mean value of IgG avidity between the three stages 
of infection was significantly different (P< 0.001). 
CONCLUSIONS 
As recently outlined [13], serologic diagnosis of acute 
7: gondii infection should be based upon the 
demonstration of a rise in antibody titers in serial serum 
samples tested in parallel. Unfortunately, often no 
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Figure 6 Distribution of IgG avidity values in patients at 
different stages of toxoplasmic infection. Cut-off value (---); 
mean values (-). Standard errors, always <lo%, have been 
omitted. 
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changes in antibody titers are observed. In these cases, 
the detection of IgM, IgA, and possibly IgE 1141, could 
be very useful in defining the stage of infection. In our 
study, the long persistence of IgM antibodies was 
confirmed. More than 50% of the samples were still 
positive after 1 year from the onset of infection. O n  the 
contrary, IgA became negative after 7 to 8 months; 
similar findings have been reported by others [7,8]. As 
emphasized by Wong and Remington [ 131, there is a 
great variability among individuals in the serologic 
response of IgM and IgA and it is not possible to predict 
how early any of these antibodies will no longer be 
demonstrable. The recent use of the IgG avidity test 
seenis to be a valid contribution to the diagnosis of 
acute infection. In this study, we confirmed the validity 
of the IgG avidity test. As seen in serum samples 
collected from patients with different serologic profiles, 
the tnean values of IgG avidity varied significantly 
according to the probable stage of infection and 
correlated with the differential detection of IgM and 
IgA. Therefore, these values could be as predictive of 
the stage of infection as the evaluation of IgG, IgM and 
IgA antibodies. This is especially iniportant when only 
one single serum sample is available. However, it could 
be difficult to establish the time of onset of infection in 
the presence of IgG avidity values ranging between 
16% and 29%. In this regard, one important finding of 
this study is that previous antibiotic administration may 
affect the kinetics of the maturation of IgG avidity. 
It  was noted that in antibiotic-treated patients an IgG 
avidity value of about 15% is reached only 5 months 
after the onset of infection. This is particularly 
important in pregnant women, in whom antibiotic 
administration significantly reduces the incidence and 
severity of fetal infection [15]. The mechanisms under- 
lying this phenomenon are as yet unclear. However, it 
is likely that antibiotic therapy, by inhibiting the 
replication of the parasite, may decrease the antigenic 
load, thus resulting in a less efficient huinoral response. 
In conclusion, the IgG avidity test may represent an 
important tool for the definition of acute 7: gondii 
infection, even though further studies are needed to 
confirm the effectiveness of this test. At present, it 
could be used in a reference laboratory as an additional 
test, particularly when a11 abriorrnal antibody profile is 
observed in pregnant women. The results should be 
interpreted together with serologic, clinical and 
anallinestic parameters, including possible antibiotic 
treatment. 
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